Allink Biotherapeutics Secures $47M to Accelerate Next-Generation ADC and Multispecific Antibody Pipeline

The company secured $47 million through extension rounds of Series A led by Legend Capital and Meituan Long-Z Investment with stron...

December 17, 2025 | Wednesday | News
Sobi Acquires Arthrosi for Up to USD 1.5 Billion, Securing Phase 3 Pozdeutinurad for Progressive Gout

Expands Sobi's pipeline with a highly differentiated new Phase 3 asset in Gout Acquisition expected to be highly accretive to...

December 15, 2025 | Monday | News
Subsense Expands Funding to $27M Following Early Breakthroughs in Nanoparticle BCI Development

After achieving early breakthroughs in materials development, in vitro nanoparticle stimulation and signal reading, Subsense secures additional $10 mil...

December 12, 2025 | Friday | News
Gilead Foundation Commits More Than $3 Million To Support Metastatic Breast Cancer Care

Gilead Foundation announced a commitment of more than $3 million in new grants to help address critical gaps in education, care delivery and support serv...

December 10, 2025 | Wednesday | News
Viatris Secures $815 Million in Strategic Exit From Biocon Biologics Stake

Viatris to Receive $400 Million in Cash and $415 Million in Equity Shares of Biocon Limited Transaction Accelerates the Expiration of Biosimilars Non-Co...

December 08, 2025 | Monday | News
Protego Biopharma Raises $130 Million to Advance PROT-001 for AL Amyloidosis

Financing led by Novartis Venture Fund and Forbion, with new investment from Omega Funds, Droia Ventures, YK Bioventures, and Digitalis Ventures ...

December 02, 2025 | Tuesday | News
Microsize Signs Agreement to Acquire Micro-Macinazione from Lonza, Strengthening Leadership in Particle Size Control

Microsize, a leading CDMO specializing in particle size reduction and control technologies, today announced it has signed an agreement to acquire Micro-M...

November 25, 2025 | Tuesday | News
AstraZeneca Invests $2 Billion to Expand Maryland Manufacturing, Doubling Biologics Capacity and Advancing U.S. Rare Disease Production

New capacity at AstraZeneca’s Fredrick and Gaithersburg facilities will accelerate production of cancer, rare and chronic disease medicines Four...

November 24, 2025 | Monday | Opinion
Novartis Announces Major North Carolina Expansion as Part of $23B U.S. Infrastructure Investment

Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030 Enables manufacturing...

November 21, 2025 | Friday | News
Profluent Raises $106M to Accelerate Frontier AI for Programmable Biology

Profluent, a leader in frontier AI for protein design,  announced a $106 million financing co-led by Altimeter Capital and Bezos Expeditions, with p...

November 20, 2025 | Thursday | News
Synthio Labs Raises $5M Seed Round to Transform Global Pharma Engagement with Clinical-Grade Voice AI

Synthio Labs, a clinical-grade voice AI company transforming how life sciences organisations engage clinicians and patients, announced that it has raised...

November 20, 2025 | Thursday | News
Repare Therapeutics Enters Definitive Agreement to Be Acquired by Xeno Therapeutics

Each shareholder is estimated to receive US$1.82 per share plus one CVR per common share - - Transaction expected to close in the first quarter of 20...

November 17, 2025 | Monday | News
Amneal Earns FDA Approval for First Generic Iohexol, Targeting $652M U.S. Market

Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced the U.S. Food and Drug Administration (FD...

November 17, 2025 | Monday | News
Angelini Ventures Expands to Asia with Singapore Hub to Power Biotech and Healthtech Innovation

Launched its first Asia office to support biotech and healthtech innovation and collaboration within the region The Asia office will house the Angelin...

November 14, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close